Suchergebnisse - "Wadler, Scott"

PubPharm (172)

1

Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors : An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution

enthalten in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2014

von Dutcher, J. | Neuberg, D. | Atkins, M. | +5

2

Report of a Phase I Evaluation of Dose and Schedule of Interleukin-1 Alpha and Cyclophosphamide in Patients with Advanced Tumors: An Eastern Cooperative Oncology Group Study (PX990) and Review of IL-1-Based Studies of Hematopoietic Reconstitution

enthalten in: Journal of interferon & cytokine research | 2014

von Dutcher, J. | Neuberg, D. | Atkins, M. | +5

3

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

enthalten in: Journal of the National Cancer Institute | 2013

von Hochster, H. | Liebes, L. | Wadler, S. | +6

4

A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer

enthalten in: Clinical colorectal cancer | 2011

von Kummar, S. | Copur, M. | Rose, M. | +10

5

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Pavlick, A. | Wu, J. | Roberts, J. | +11

6

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Pavlick, A. | Wu, J. | Roberts, J. | +11

7

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Pavlick, A. | Wu, J. | Roberts, J. | +11

8

Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan : a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803)

enthalten in: Cancer | 2009

von Grinblatt, D. | Yu, D. | Hars, V. | +28

9

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer : findings from Cancer and Leukemia Group B 89803

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2008

von Meyerhardt, J. | Niedzwiecki, D. | Hollis, D. | +44

CommentIn: J Clin Oncol. 2008 Sep 1;26(25):4060-2. - PMID 18757320

10

Molecular Targeting in Oncology

Erschienen: Totowa, NJ, Humana Press, 2008

Cancer Drug Discovery and Development

von Kaufman, H. | Wadler, S. | Antman, K.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]